Exelixis (EXEL) PT Raised to $52 at UBS on Upcoming Catalysts

July 2, 2026 8:31 AM

UBS analyst Ashwani Verma raised the price target on Exelixis (NASDAQ: EXEL) to $52.00 (from $43.00) while maintaining a Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found